KNSA SCHEDULE 13G/A: SEC filing
Rubric Capital Management LP
Filed with the SEC on · accession 0001104659-26-128329
KNSA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Rubric Capital Management LP filed an amended Schedule 13G reporting beneficial ownership of 2,813,469 Class A ordinary shares of Kiniksa Pharmaceuticals, representing 5.83% of the outstanding shares as of September 30, 2026.
Summary of the filing
Rubric Capital Management LP filed an amended Schedule 13G reporting beneficial ownership of 2,813,469 Class A ordinary shares of Kiniksa Pharmaceuticals, representing 5.83% of the outstanding shares as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control of the company.
Key details
✦ Ask GOAX AI about this filing — what it means for KNSA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for KNSA?
Click hereFrequently asked questions
What did KNSA file with the SEC on Nov 16, 2026?
KNSA filed a SCHEDULE 13G/A (SEC filing). Rubric Capital Management LP filed an amended Schedule 13G reporting beneficial ownership of 2,813,469 Class A ordinary shares of Kiniksa Pharmaceuticals, representing 5.83% of the outstanding shares as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control of the company.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other KNSA SEC filings
- 10-Q · SEC filingOct 27, 2026
- 8-K · SEC filingOct 27, 2026
- 8-K · Executive departureOct 22, 2026
- 8-K · SEC filingJul 28, 2026
- 10-Q · SEC filingJul 28, 2026
- 8-K · Board changeMay 29, 2026
- 8-K · SEC filingMay 26, 2026
- 8-K · Executive departureMay 1, 2026
- 144 · Insider sale plannedMay 1, 2026
- 144 · Insider sale plannedApr 28, 2026
Get alerts when KNSA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days